AMRI provides you with all of the tools to successfully complete your PALS recertification. Our course is fast and flexible. Renew your PALS Certification today!
Breast cancer was responsible for half a million deaths worldwide in 2012. In that same year, more than 1.7 million people were diagnosed with this deadly disease. Early detection and treatment of breast cancer significantly increases one’s chances of survival, so annual screening through mammography is recommended for all women over the age of 40.
In 1992, the Breast Imaging Team at Massachusetts General Hospital began researching the use of breast tomosynthesis as an alternative to mammograms. This new technology, which creates a 3-D image of breast tissue, was approved by the FDA in 2011. Today breast tomosynthesis plus digital mammography is the standard protocol for all breast cancer screenings performed at Mass General.
The use of this new technology, however, is not yet the standard diagnostic tool nationwide. Though it has a number of benefits, its few disadvantages are preventing many from adopting it at this time.
There are a number of ways in which breast tomosynthesis is proving superior to traditional mammography. These advantages include:
Although this new technology is proving valuable and worthwhile, its use as a standard protocol is being slowly adopted. The reasons are:
“We believe that this technology will become commonplace in the near future,” Kristina Lang and Sophia Zackrisson, two of the researchers from the Lund University study, state. “We see a change as inevitable. Breast tomosynthesis will be introduced, it is just a question of when and on what scale.”
Zackrisson adds that, “We see five to ten years from now as a possible timeframe for the large-scale introduction of the technique. There is also an aspiration for more personalized screening, and breast tomosynthesis could therefore be one of several methods used.”
You can learn more about breast tomosynthesis here.